Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells.
Infection of BHK cells by Sindbis virus leads to rapid inhibition of host cell protein synthesis and cytopathic effects (CPE). We have been studying these events to determine whether the expression of a specific viral gene is required and, in the present study, have focused our attention on the role of the structural proteins--the capsid protein and the two membrane glycoproteins. We tested a variety of Sindbis viruses and Sindbis virus replicons (virus particles containing an RNA that is self-replicating but with some or all of the viral structural protein genes deleted) for their abilities to inhibit host cell protein synthesis and cause CPE in infected BHK cells. Our results show that shutoff of host cell protein synthesis occurred in infected BHK cells when no viral structural proteins were synthesized and also under conditions in which the level of the viral subgenomic RNA was too low to be detected. These results support the conclusion that the early steps in viral gene expression are the ones required for the inhibition of host cell protein synthesis in BHK cells. In contrast, the Sindbis viruses and Sindbis virus replicons were clearly distinguished by the time at which CPE became evident. Viruses that synthesized high levels of the two membrane glycoproteins on the surface of the infected cells caused a rapid (12 to 16 h postinfection) appearance of CPE, and those that did not synthesize the glycoprotein spikes showed delayed (30 to 40 h) CPE.
Frolov
I
I
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110-1093.
Schlesinger
S
S
D000818:Animals; D002213:Capsid / Q000494:pharmacology; D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D006224:Cricetinae; D003588:Cytopathogenic Effect, Viral; D015870:Gene Expression; D007668:Kidney / Q000166:cytology; D008156:Luciferases / Q000096:biosynthesis; D014176:Protein Biosynthesis / Q000187:drug effects*; D012367:RNA, Viral / Q000494:pharmacology; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012093:Replicon; D012845:Sindbis Virus / Q000472:pathogenicity*; D014158:Transcription, Genetic; D014763:Viral Matrix Proteins / Q000494:pharmacology; D015678:Viral Structural Proteins / Q000494:pharmacology*
D012367:RNA, Viral; D011993:Recombinant Fusion Proteins; D014763:Viral Matrix Proteins; D015678:Viral Structural Proteins; D008156:Luciferases